At-Home Testing Kits Market Size, Share, and Industry Analysis, By Test Type (Infectious Disease Tests, Pregnancy, Ovulation, & Fertility Testing Tests, Cancer Screening Tests, Glucose Tests, Genetic Tests, and Others), By Type (Cassette, Strip, Dip Card, and Others), By Sample Type (Blood, Urine, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2024-2032

At-home testing kits are convenient tools that allow individuals to test for, screen, or monitor various medical conditions in the comfort of their own homes. These kits can be purchased online or at local pharmacies and supermarkets without the need for a doctor's prescription. Common types of at-home tests include pregnancy tests, glucose tests for managing diabetes, fecal occult blood tests for colon cancer screening, tests for infectious diseases, such as hepatitis, HIV, and COVID-19, and genetic tests that assess the risk of certain diseases.

At-home testing involves collecting samples of body fluids such as blood, urine, saliva, stool, or nasal swabs, depending on the specific test. These tests provide rapid results in the comfort of home, eliminating the need for prescriptions, doctor visits, and mailing back a sample to the laboratory. Furthermore, these tests serve various purposes, such as the early detection of disorders before symptoms appear, diagnosing pregnancy, monitoring chronic conditions such as diabetes and high blood pressure, and screening for infectious diseases.

The global market growth of at-home testing kits is attributed to the increasing burden of several diseases, such as infectious diseases and chronic diseases. Early detection of these diseases by utilizing the at-home testing kits helps individuals seek timely treatment, make lifestyle changes, and prevent the spread of such diseases.

• For instance, as of March 2024, according to the European Center for Disease Prevention and Control, HIV cases significantly increased in 2022, with gonorrhea cases rising by 48.0%, chlamydia cases by 16.0%, and syphilis cases by 34.0%. These rising cases are expected to boost the adoption of at-home testing kits, driving the market growth during the forecast period.

Moreover, these kits are leading to expanding access to healthcare in remote areas or those with mobility issues. These kits make healthcare more accessible by eliminating the need to travel. In addition, these kits offer several benefits, such as cost savings, convenience, ease of use, and quicker results. These benefits of at-home testing kits are expected to surge global demand, propelling market growth in the forthcoming years.

The COVID-19 pandemic exerted a positive impact on the at-home testing kits market. The pandemic led to an increased demand for at-home testing kits due to a surge in the number of COVID-19 infections and the temporary closure of several healthcare facilities.

• For instance, as of April 2023, according to the National Center for Biotechnology Information (NCBI), the U.S. FDA first authorized the at-home rapid antigen COVID-19 tests in late 2020. This boosted the shipping rate of at-home testing kits during the pandemic, which fueled the market growth in 2020.

Segmentation

Key Insights

The report covers the following key insights:

• Technological Advancements in At-Home Testing


• New Product Launches by Key Players


• Key Industry Developments (Mergers, Acquisitions, and Partnerships)


• Regulatory Overview of At-Home Testing - by Key Countries/Regions


• Impact of COVID-19 on the Market         

Analysis by Test Type

Based on test type, the market is segmented into infectious disease tests, pregnancy, ovulation, & fertility testing tests, cancer screening tests, glucose tests, genetic tests, and others. The infectious disease test segment is projected to account for a significant share of the global at-home testing kits market during the forecast period. This growth is attributed to the rising use of at-home testing kits and the growing awareness of the early detection of these diseases owing to the high burden of such diseases. To contribute to overcoming this high disease burden, the regulatory authorities are increasingly granting approvals for at-home testing kits, which is expected to boost product availability and significantly drive segment growth.

• For instance, as of November 2023, the U.S. FDA granted marketing authorization for the over-the-counter (OTC) Simple 2 Test for detecting gonorrhea and chlamydia in adults.

On the other hand, the pregnancy, ovulation, and fertility tests segment is projected to expand at a noteworthy CAGR in the forthcoming years. This growth is attributed to the growing demand for at-home pregnancy and ovulation testing, which is stimulating several key players to introduce launch products. Moreover, the falling fertility rate and rising concerns regarding both male and female infertility are significantly driving the demand for at-home fertility testing kits, which is anticipated to boost segmental growth.

Regional Analysis

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to hold a significant share of the at-home testing kits market during the forecast period. The presence of significant key players focusing on advancements in at-home testing kits is expected to surge the demand for such kits in the region. Furthermore, the increasing popularity of self-testing pregnancy kits amongst the women demographic in the region is also expected to drive the adoption of at-home testing kits, propelling the market growth. Moreover, there is an increasing incidence of drug abuse in the region, which is further expected to surge the adoption of at-home drug abuse testing kits in the region.

• For instance, as of February 2023, the U.S. National Center for Drug Abuse Statistics (NCDAS) stated that 46.0% of U.S. drug users report using cannabis and prescription stimulants, 36.0% of opioids and methamphetamine, 31.0% of prescription stimulants, 15.0% heroin and 10% cocaine.

Asia Pacific is projected to grow at a significant CAGR during the forecast timeframe. This growth is mainly due to the growing trend of people taking a more proactive approach to their health, driving the demand for at-home testing kits in the region. Furthermore, as the at-home tests provide more affordability compared to lab tests or doctor visits, these kits are expected to become more accessible to a wider population, propelling regional growth.

Key Players Covered

The market consists of significant players, such as Pfizer Inc., Abbott, ACON Laboratories, Inc., Exact Sciences Corporation, Everlywell, Inc., Quidel Corporation, Cardinal Health, Pinnacle BioLabs, OraSure Technologies Inc., and BD. The increasing focus of these players on new technologically advanced product launches has been fueling their revenue growth.

Key Industry Developments

• In April 2024, Laboratory Corporation of America Holdings announced that the U.S. FDA had granted emergency use authorization for the Mpox PCR Test Home Collection Kit to diagnose the infection with non-variola Orthopoxvirus.


• In June 2023, Simple HealthKit Inc. partnered with Walmart to make its home diagnostic test kits for sexual wellness, diabetes, and respiratory health available to customers through the retail chain's website.


• In July 2021, Abbott launched a COVID-19 home test kit in India to detect the SARS-CoV-2 virus in children and adults.